Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)

Telavancin is a bactericidal lipoglycopeptide antibiotic that is structurally related to vancomycin. It demonstrates in vitro activity against a variety of Gram-positive pathogens including, but not limited to, methicillin-resistant Staphylococcus aureus (MRSA). Telavancin is currently FDA-approved...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hooper, Candace Y, Smith, Winter J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2012
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3333464/
https://ncbi.nlm.nih.gov/pubmed/22547931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S23247
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller